Chromosomes and cancer: from molecules to man, [5th Annual Bristol-Myers symposium on cancer research, University of Chicago Cancer Research Center, October 18-19, 1982]ROWLEY, Janet D; ULTMANN, John E.Chromosomes and cancer: from molecules to man. Symposium. 1983, XXII-357 p, isbn 0-12-600250-9Conference Proceedings

Is Hodgkin's disease an infectious disease?WOLF, J; DIEHL, V.Annals of oncology. 1994, Vol 5, pp S105-S111, issn 0923-7534, SUP1Conference Paper

Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangementWILLIAMS, M. E; SWERDLOW, S. H.Annals of oncology. 1994, Vol 5, pp S71-S73, issn 0923-7534, SUP1Conference Paper

Lymphokine receptors: a target for immunotherapy of lymphomasWALDMANN, T. A.Annals of oncology. 1994, Vol 5, pp S13-S17, issn 0923-7534, SUP1Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entityKADIN, M. E.Annals of oncology. 1994, Vol 5, pp S25-S30, issn 0923-7534, SUP1Conference Paper

Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemicWEISENBURGER, D. D.Annals of oncology. 1994, Vol 5, pp S19-S24, issn 0923-7534, SUP1Conference Paper

Pediatric lymphomas: recent advances and commentary on Ki-1-positive anaplastic large-cell lymphomas of childhoodMURPHY, S. B.Annals of oncology. 1994, Vol 5, pp S31-S33, issn 0923-7534, SUP1Conference Paper

A reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphomaSTRAKA, C; PETTENGELL, R; PIELMEIER, A et al.Annals of oncology. 1994, Vol 5, pp S79-S84, issn 0923-7534, SUP1Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

Proliferation of Reed-Sternberg cells and variants in Hodgkin's diseaseGUPTA, R. K; LISTER, T. A; BODMER, J. G et al.Annals of oncology. 1994, Vol 5, pp S117-S119, issn 0923-7534, SUP1Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomasJAFFE, E. S; ZARATE-OSORNO, A; KINGMA, D. W et al.Annals of oncology. 1994, Vol 5, pp S7-S11, issn 0923-7534, SUP1Conference Paper

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas : results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhCM-CSFENGELHARD, M; GERHARTZ, H; LUDWIG, W.-D et al.Annals of oncology. 1994, Vol 5, pp 123-125, issn 0923-7534, SUP2Conference Paper

Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin's lymphomasREA, D; DELECLUSE, H.-J; HAMILTON-DUTOIT, S. J et al.Annals of oncology. 1994, Vol 5, pp S113-S116, issn 0923-7534, SUP1Conference Paper

Investigation of the activation state of the X chromosome in non-Hodgkin's lymphomasGRIERSON, A. J; HAMMOND, D. W; GOEPEL, J. R et al.Annals of oncology. 1994, Vol 5, pp S47-S50, issn 0923-7534, SUP1Conference Paper

Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomasHAGEMEISTER, F. B; KHETAN, R; ALLEN, P et al.Annals of oncology. 1994, Vol 5, pp 41-46, issn 0923-7534, SUP2Conference Paper

Analysis of the p53 gene, its expression and protein stabilization in non-Hodgkin's lymphomasLEE, K. A; FINNEGAN, M. C. M; SHERIDAN, E et al.Annals of oncology. 1994, Vol 5, pp S85-S88, issn 0923-7534, SUP1Conference Paper

Chromosome analysis of non-Hodgkin's lymphomas by fluorescence in situ hybridizationHAMMOND, D. W; HANCOCK, B. W; GOYNS, M. H et al.Annals of oncology. 1994, Vol 5, pp S51-S54, issn 0923-7534, SUP1Conference Paper

Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID miceKAPP, U; DÜX, A; DIEHL, V et al.Annals of oncology. 1994, Vol 5, pp S121-S126, issn 0923-7534, SUP1Conference Paper

Identification of genetic lesions associated with diffuse large-cell lymphomaDALLA-FAVERA, R; YE, B. H; LO COCO, F et al.Annals of oncology. 1994, Vol 5, pp S55-S60, issn 0923-7534, SUP1Conference Paper

In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assayNYGREN, P; HAGBERG, H; GLIMELIUS, B et al.Annals of oncology. 1994, Vol 5, pp S127-S131, issn 0923-7534, SUP1Conference Paper

Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's diseaseNOORDIJK, E. M; CARDE, P; HENRY-AMAR, M et al.Annals of oncology. 1994, Vol 5, pp 107-112, issn 0923-7534, SUP2Conference Paper